Blume-Jensen Peter
CIK 1950499
Transactions on file
21
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-27 | 2026-08-25 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Sale | 14,036 | $31.0K | -22.0% | open → |
| 2026-08-20 | 2026-08-18 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Sale | 484 | $972.84 | -14.4% | open → |
| 2026-08-20 | 2026-08-18 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Sale | 1,229 | $2.5K | -14.4% | open → |
| 2026-05-26 | 2026-05-21 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 13,729 | $24.6K | -3.9% | open → |
| 2026-05-20 | 2026-05-18 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Grant | 72,706 | $0.00 | — | open → |
| 2026-05-20 | 2026-05-18 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Grant | 180,095 | $0.00 | — | open → |
| 2026-05-18 | 2026-05-14 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 490 | $940.80 | -10.4% | open → |
| 2026-05-18 | 2026-05-14 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 1,253 | $2.4K | -10.4% | open → |
| 2025-02-19 | 2025-02-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 579 | $3.1K | -68.3% | open → |
| 2025-02-19 | 2025-02-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 37,152 | $201.4K | -68.3% | open → |
| 2025-02-25 | 2025-02-21 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 19,904 | $110.3K | -69.0% | open → |
| 2025-05-16 | 2025-05-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 59,766 | $68.1K | +50.9% | open → |
| 2025-05-16 | 2025-05-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 491 | $559.74 | +50.9% | open → |
| 2025-05-23 | 2025-05-21 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 19,904 | $22.9K | +49.6% | open → |
| 2026-02-24 | 2026-02-21 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 14,265 | $21.8K | +12.4% | open → |
| 2025-11-25 | 2025-11-21 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 19,904 | $45.8K | -25.2% | open → |
| 2025-11-18 | 2025-11-14 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 490 | $1.1K | -23.2% | open → |
| 2025-11-18 | 2025-11-14 | ACRV Acrivon Therapeutics, Inc. | President and CEO | Tax | 59,765 | $133.9K | -23.2% | open → |
| 2025-08-18 | 2025-08-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 59,766 | $83.1K | +23.7% | open → |
| 2025-08-18 | 2025-08-14 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 490 | $681.10 | +23.7% | open → |
| 2025-08-25 | 2025-08-21 | ACRV Acrivon Therapeutics, Inc. | OfficerDirector President and CEO | Tax | 19,905 | $26.3K | +30.3% | open → |
